- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07798869
Genu Varum, Change of Direction, and Reactive Agility in Youth Football Players
Does Genu Varum Influence Change of Direction and Reactive Agility Performance in Youth Football Players?
The goal of this observational study is to compare change-of-direction (COD) and reactive agility (RA) performance between football players with and without genu varum and to examine whether lower-limb alignment is associated with these performance measures.
The main questions it aims to answer are:
- Do football players with and without genu varum differ in COD and RA performance?
- Is lower-limb alignment associated with COD and RA performance in football players with and without genu varum?
Football players with and without genu varum will undergo assessments of lower-limb alignment, COD performance, and RA performance. The study will compare performance between the two groups and examine the relationship between lower-limb alignment and performance measures.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Antalya, Turkey (Türkiye)
- Akdeniz University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- At least five years of football experience
- Participation in football training at least five days per week
- Voluntary participation in the study
Exclusion Criteria:
- History of lower extremity surgery
- Current musculoskeletal injury affecting performance
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Genu Varum Group
Football players with genu varum who will be assessed for lower-limb alignment, change-of-direction performance, and reactive agility performance.
|
|
Control Group
Football players without genu varum who will be assessed for lower-limb alignment, change-of-direction performance, and reactive agility performance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change-of-direction performance
Time Frame: at basline
|
Change-of-direction performance will be assessed using the SpeedCourt system (Globalspeed GmbH, Hemsbach, Germany).
The test consists of a 14.5-m running course with four changes of direction.
Performance will be evaluated based on total completion time, with lower times indicating better change-of-direction performance.
|
at basline
|
|
Reactive agility performance
Time Frame: at basline
|
Reactive agility performance will be assessed using the SpeedCourt system (Globalspeed GmbH, Hemsbach, Germany).
Participants will respond as quickly and accurately as possible to randomly presented visual stimuli and perform the required directional movements.
Performance will be evaluated based on total completion time, with lower times indicating better reactive agility performance.
|
at basline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intercondylar distance and intermalleolar distance
Time Frame: at basline
|
Lower-limb alignment will be assessed by measuring intercondylar distance (ICD) and intermalleolar distance (IMD) in centimeters.
ICD will be measured as the distance between the medial femoral condyles, and IMD as the distance between the medial malleoli, using a standardized measurement procedure.
|
at basline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-89
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.